Mankind Pharma Limited Mankind Pharma Limited

Mankind Pharma Limited

MANKIND

Rangering i aksjer #2064
Mankind Pharma Limited specializes in the development, manufacturing, and... Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
Aksjekurs
$24.08
Markedsverdi
$9.95B
Endring (1 dag)
-4.09%
Endring (1 år)
-13.33%
Land
IN
Handel Mankind Pharma Limited (MANKIND)

Kategori

Healthcare
Antall utestående aksjer for Mankind Pharma Limited (MANKIND)
Antall utestående aksjer per October 2026: 0
Ifølge Mankind Pharma Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av October 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Mankind Pharma Limited (MANKIND) fra 2019 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2025 404.67M 1.02%
2024 400.59M 0.00%
2023 400.59M 0.00%
2022 400.59M 0.00%
2021 400.59M 0.00%
2020 400.59M 0.00%
2019 400.59M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter